Cargando…

Targeting Apoptosis in AML: Where Do We Stand?

SIMPLE SUMMARY: In patients with acute myeloid leukemia (AML), genetic mutations can cause cells to evade regulated cell death (RCD), resulting in excessive cell proliferation. The best-known form of RCD is apoptosis, which prevents the emergence of cancer cells; disturbances in this process are an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krawiec, Kinga, Strzałka, Piotr, Czemerska, Magdalena, Wiśnik, Aneta, Zawlik, Izabela, Wierzbowska, Agnieszka, Pluta, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600036/ https://www.ncbi.nlm.nih.gov/pubmed/36291779 http://dx.doi.org/10.3390/cancers14204995

Ejemplares similares

P551: EVALUATION OF PROGNOSTIC FACTORS FOR SURVIVAL AND TREATMENT OUTCOMES OF PATIENTS WITH SECONDARY ACUTE MYELOID LEUKEMIA – A SINGLE-CENTER STUDY
por: Strzałka, Piotr, et al.
Publicado: (2023)

PB2430: EVALUATION OF OUTCOME AND SAFETY PROFILE IN HIGH-DOSE BEAM AND BEEAM CHEMOTHERAPY WITH SUBSEQUENT AUTOLOGOUS STEM CELL TRANSPLANTATION IN LYMPHOMA PATIENTS – SINGLE-CENTER EXPERIENCE
por: Krawiec, Kinga, et al.
Publicado: (2023)

Where Do We Stand?
Publicado: (1891)

Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)

P1535: ASSESSMENT OF COLONIZATION AND INFECTION EPIDEMIOLOGY IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION – A PROSPECTIVE MULTI-CENTER STUDY OF POLISH ADULT LEUKEMIA GROUP (PALG).
por: Pluta, Agnieszka, et al.
Publicado: (2023)

Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017)

Alterations in microRNA Expression during Hematopoietic Stem Cell Mobilization
por: Nowicki, Mateusz, et al.
Publicado: (2021)

ColVI myopathies: where do we stand, where do we go?
por: Allamand, Valérie, et al.
Publicado: (2011)

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients
por: Pluta, Agnieszka, et al.
Publicado: (2019)

Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)

Pixel Detectors ... where do we stand?
por: Wermes, Norbert
Publicado: (2019)

Laser accelerators : where do we stand
por: Lawson, J D
Publicado: (1985)

Renormalization schemes: where do we stand?
por: Ward, B F L
Publicado: (1990)

Barrett's Esophagus: Where Do We Stand?
por: Al Madi, Majid A.
Publicado: (2009)

Maximizing neuroprotection: where do we stand?
por: Kuffler, Damien P
Publicado: (2012)

LHC Access - Where do we Stand
por: Ninin, P, et al.
Publicado: (2006)

Where do we stand with IPF treatment?
por: Albera, C, et al.
Publicado: (2013)

Genetics of Keratoconus: Where Do We Stand?
por: Abu-Amero, Khaled K., et al.
Publicado: (2014)

Cricoid pressure: Where do we stand?
por: Bhatia, Nidhi, et al.
Publicado: (2014)

Combating Malaria: Where do We Stand?
por: Coats, Mamie T
Publicado: (2016)

Where Do We Stand in Preventive Medicine?
por: Robertson, Wm.
Publicado: (1921)

Bevacizumab in Glaucoma: Where do We Stand?
por: Khanna, Anjani
Publicado: (2012)

Schistosomiasis vaccines: where do we stand?
por: Tebeje, Biniam Mathewos, et al.
Publicado: (2016)

Dupuytren’s disease: where do we stand?
por: Grazina, Rita, et al.
Publicado: (2019)

Telemedicine in India: Where do we stand?
por: Chellaiyan, Vinoth G., et al.
Publicado: (2019)

Imaging of the spine: Where do we stand?
por: Nouh, Mohamed R
Publicado: (2019)

Autoimmune Myopathies: Where Do We Stand?
por: Simon, Jean-Philippe, et al.
Publicado: (2016)

Phytotherapy for Cachexia: Where Do We Stand?
por: Kuchta, Kenny, et al.
Publicado: (2020)

Vaccine for Diabetes—Where Do We Stand?
por: Chellappan, Dinesh Kumar, et al.
Publicado: (2022)

Microbiological surveillance – where do we stand?
por: Beilenhoff, Ulrike
Publicado: (2023)

The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
por: Agapidou, Alexandra, et al.
Publicado: (2016)

Scoping review of brucellosis in Cameroon: Where do we stand, and where are we going?
por: Laine, Christopher G., et al.
Publicado: (2020)

Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
por: Horváth, Balázs, et al.
Publicado: (2022)

Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)

The toxicity of methyl isocyanate: Where do we stand?
por: Bucher, John R.
Publicado: (1987)

Safety and access control: Where do we stand?
por: Ninin, P
Publicado: (2004)

LHC beams in the SPS: where do we stand?
por: Arduini, Gianluigi
Publicado: (2004)

The Hippocampus and Imagining the Future: Where Do We Stand?
por: Addis, Donna Rose, et al.
Publicado: (2012)

Cost of AF Ablation: Where Do We Stand?
por: Khaykin, Yaariv, et al.
Publicado: (2011)

Where do we stand in high-energy physics?
por: CERN Press Office. Geneva
Publicado: (1962)

Cannot write session to /tmp/vufind_sessions/sess_j7u529m550mthfc68dhrb4g1r1